AI could make drug discovery faster and help smaller research labs tackle complex scientific problems. But there's a catch – ...
Drug discovery is one of the most expensive pursuits in modern industry. Finding a single viable molecule can take a decade and cost billions, and most candidates still don’t make it. A generation of ...
The Physical Lab Bottleneck: While AI can design prospective drug molecules in seconds, validating whether they work still depends on slow physical wet-lab testing and custom testing tools. Danaher’s ...
For drug discovery, protein-folding models such as AlphaFold have a problem: there aren’t enough data in public databases. Improving the performance of these artificial-intelligence-based tools will ...
ast June, when AI drug discovery startup Chai Discovery was just 15 months old, it released a new model that could design antibodies. Nearly 20 pharma companies reached out to talk. “It was like we ...
As general-purpose and domain-specific AI models rapidly infiltrate drug discovery, one critical question looms over the pharmaceutical sector: Can these models actually discover drugs, or are they ...
Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced the release of a series of frontier specialist models for chemistry and ...
Pharmaceutical company Novo Nordisk and Anthropic announced a collaboration to use Anthropic's AI assistant Claude to support drug discovery and software development. The companies will identify ...